Filing Details
- Accession Number:
- 0001371285-18-000228
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-15 18:01:16
- Reporting Period:
- 2018-11-13
- Accepted Time:
- 2018-11-15 18:01:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1371285 | Trupanion Inc. | TRUP | Hospital & Medical Service Plans (6324) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1560444 | A Robin Ferracone | 201 South Lake Avenue Suite 804 Pasadena CA 91101 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-06-01 | 750 | $0.00 | 1,502 | No | 5 | G | Direct | |
Common Stock | Acquisiton | 2018-06-01 | 750 | $0.00 | 35,056 | No | 5 | G | Indirect | By Robin A. Ferracone TTEE of the Robin A. Ferracone Living Trust dtd 6/3/2002 |
Common Stock | Acquisiton | 2018-11-13 | 19,000 | $25.60 | 54,056 | No | 4 | P | Indirect | By Robin A. Ferracone TTEE of the Robin A. Ferracone Living Trust dtd 6/3/2002 |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | G | Direct | |
No | 5 | G | Indirect | By Robin A. Ferracone TTEE of the Robin A. Ferracone Living Trust dtd 6/3/2002 |
No | 4 | P | Indirect | By Robin A. Ferracone TTEE of the Robin A. Ferracone Living Trust dtd 6/3/2002 |
Footnotes
- Represents transfer of shares to a trust the holdings of which are attributable to the reporting person.
- Shares held of record by Robin A. Ferracone TTEE of the Robin A. Ferracone Living Trust dtd 6/3/2002, of which the reporting person is a beneficiary.
- The reported price in Column 4 is the weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.070 to $25.80 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.